<code id='313ED06067'></code><style id='313ED06067'></style>
    • <acronym id='313ED06067'></acronym>
      <center id='313ED06067'><center id='313ED06067'><tfoot id='313ED06067'></tfoot></center><abbr id='313ED06067'><dir id='313ED06067'><tfoot id='313ED06067'></tfoot><noframes id='313ED06067'>

    • <optgroup id='313ED06067'><strike id='313ED06067'><sup id='313ED06067'></sup></strike><code id='313ED06067'></code></optgroup>
        1. <b id='313ED06067'><label id='313ED06067'><select id='313ED06067'><dt id='313ED06067'><span id='313ED06067'></span></dt></select></label></b><u id='313ED06067'></u>
          <i id='313ED06067'><strike id='313ED06067'><tt id='313ED06067'><pre id='313ED06067'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:6
          Red Blood Cells
          Adobe

          The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

          The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

          advertisement

          Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Senators tussle over abortion against the backdrop of a presidential campaign
          Senators tussle over abortion against the backdrop of a presidential campaign

          Sen.BillCassidy(R-La.),amemberofthechamber'shealthcommittee,saidduringthehearing:“It'spartisanpoliti

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          Eli Lilly’s Zepbound improved liver scarring in mid

          Illustration:STAT;Source:EliLilly/APEliLilly’sblockbusterdiabetesandobesitydrugimprovedlivingscarrin